Dr.ASHOK KUMAR, K13270
Purpose:To report two cases of to and fro migration of ozurdex implant in patients with scleral fixated posterior chamber IOL which were successfully managed . Method: Case 1 was a patient of VKH disease with scleral fixated IOL who was treated with Ozurdex to control cystoid macular edema(CME) and inflammation. 2nd patient, a case of surgical aphakia followed by scleral fixated IOL who developed pseudophakic CME and managed with ozurdex implant. Both patients showed anterior chamber migration of implant which were repositioned with supine posturing and use of pilocarpine drops. Implants again migrated into anterior chamber and managed with surgical extraction. CONCLUSION:Patients with scleral fixated PCIOL presents a high risk of anterior chamber migration of the Ozurdex implant. Prompt repositioning of implant or removal in case of wandering ozurdex implant can reduce risk of endothelial decompensation. In such cases, anti-VEGF therapies should be discussed as an alternative.
Leave a Comment